Trials / Completed
CompletedNCT05992467
WECARE: A Behavioral Intervention for Dementia Caregivers
WECARE: A mHealth Intervention to Enhance Caregiving Mastery Among Chinese American Dementia Caregivers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- George Mason University · Academic / Other
- Sex
- All
- Age
- 21 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
This study aims to pilot test a culturally tailored behavioral intervention called "WECARE" to enhance caregiving mastery and improve psychosocial wellbeing of Chinese American family caregivers of persons with Alzheimer's Disease and related dementia.
Detailed description
The investigators propose to test a culturally tailored mHealth behavioral intervention to enhance caregiving mastery and improve psychosocial wellbeing among Chinese American family caregivers of persons living with Alzheimer's Disease and related dementia. This intervention, Wellness Enhancement for Caregivers (WECARE), will be delivered via WeChat, a social media app highly popular among Chinese Americans. About 45 participants will be recruited for the pilot test. Participants will complete a baseline survey, receive 7-week WECARE program on their WeChat accounts, complete a follow-up survey 12 weeks after the baseline, and then a qualitative interview on Zoom.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Wellness Enhancement for Caregivers (WECARE) | WECARE behavioral intervention is guided by behavioral theories aimed to increase participants' caregiving mastery, enhance self-care, and improve psychosocial wellbeing. Participants will receive multimedia content on their WeChat account on cellphone or tablet, including short video clips, pictorial messages, short articles, and audio recordings 6 days a week, for 7 weeks. |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2024-08-31
- Completion
- 2024-08-31
- First posted
- 2023-08-15
- Last updated
- 2024-10-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05992467. Inclusion in this directory is not an endorsement.